House Committee Grills Drug Executives Over Pricing Practices for Generics

By March 8, 2016 Generic Line No Comments

Democrats and Republicans of the House Oversight Committee took executives of Valeant Pharmaceuticals and Turing Pharmaceuticals to task Feb. 4 over what members called a strategy of buying old drugs with no generic competition and “jacking up” the prices for profits.
Source: Generic Line